Thomas Naert, PhD, received an individual postdoctoral fellowship in the frame of the Marie Skłodowska-Curie Actions, Horizon 2020 program. The program funds researchers mobility in all areas of science and is one of the most prestigious and competitive funding schemes worldwide. Thomas will use the CRISPR/Cas9 method to model congenital kidney diseases in X. tropicalis. He aims to find novel diagnostic tools and new druggable therapeutic targets with his studies. Congratulations and good success Thomas!